|
|
||||||||
LETTERS TO THE EDITOR |
Institute of Internal Medicine
Catholic University
Largo A. Gemelli, 8
00168 Rome
Italy
E-mail: melania.manco{at}rm.unicatt.it
Dear Sir:
Chiu et al (1) provide elegant evidence that the 25-hydroxyvitamin D [25(OH)D] concentration has a positive relation to insulin sensitivity in healthy, nearly normal-weight, glucose-tolerant subjects. They conclude that a low concentration of 25(OH)D can be an independent risk factor for metabolic syndrome in large populations.
We have some concerns. First, the authors recognize the significant relation between serum concentrations of 25(OH)D and latitude in the European population (2). Thus, we should infer a correlation between latitude and insulin sensitivity. The European Group of Insulin Resistance failed to find any correlation between latitude and insulin sensitivity in a cohort of 1146 European subjects (3). Moreover, because concentrations of 25(OH)D depend on sunlight exposure (4, 5), for each patient we could find seasonal differences in insulin sensitivity. The authors report a marginal effect (P = 0.0729) of season on 25(OH)D, which could be biased by the prevalence of subjects studied or by the time definition for each season.
Second, the incidence of metabolic syndrome was 30% in 47 subjects with hypovitaminosis D (<20 ng/mL) compared with 11% in 79 subjects with normal concentrations of 25(OH)D. Because the 25(OH)D concentration was an independent predictor for BMI, was BMI equally distributed between the 2 groups? Moreover, the authors did not provide data on body composition. The percentage of fat is inversely related to the serum 25(OH)D concentration (5). A high percentage of body fat could play a key role in explaining the relation between low serum vitamin D concentrations and insulin resistance.
The last, but main, concern comes from evidence of hypovitaminosis D coupled with normal insulin sensitivity in obese subjects undergoing biliopancreatic diversion (BPD), a type of bariatric surgery (6). BPD basically causes weight loss through severe lipid malabsorption (6) and leads to mild-to-severe hypocalcemia, low concentrations of vitamin D, and hyperparathyroidism in large cohorts of subjects (7, 8). BPD patients do not have serum 25(OH)D concentrations that are higher than those of obese subjects (9). However, BPD increases insulin sensitivity up to 3-fold with respect to baseline (10) and significantly reduces fat mass and cardiovascular disease risk (11).
REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |